Advantage Alpha Capital Partners LP Arcturus Therapeutics Holdings Inc. Transaction History
Advantage Alpha Capital Partners LP
- $515 Million
- Q1 2024
A detailed history of Advantage Alpha Capital Partners LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 29,881 shares of ARCT stock, worth $641,843. This represents 0.2% of its overall portfolio holdings.
Number of Shares
29,881
Previous 50,524
40.86%
Holding current value
$641,843
Previous $1.59 Million
36.66%
% of portfolio
0.2%
Previous 0.31%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
196Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$101 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$58.9 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$42.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$36.3 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$29.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $571M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...